Location History:
- Annapolis, MD (US) (2014)
- San Diego, CA (US) (2015)
Company Filing History:
Years Active: 2014-2015
Title: Kalvin Yim - Innovator in Biopharmaceuticals
Introduction
Kalvin Yim is a notable inventor based in San Diego, California, known for his contributions to the field of biopharmaceuticals. With two patents to his name, he has made significant strides in the development of butyrylcholinesterases, which play a critical role in various biological applications.
Latest Patents
Kalvin's latest patents include groundbreaking work on recombinant butyrylcholinesterases and their truncated forms. These patents disclose isolated nucleic acids encoding polypeptides that exhibit butyrylcholinesterase (BChE) enzyme activity. The patents detail molecular criteria for preparing these nucleic acids, including codon optimization. Additionally, they describe methods for preparing modified and/or truncated BChE molecules with selected properties, focusing on the selective formation of monomers. Vectors and cells that contain and/or express these nucleic acids are also disclosed, showcasing the potential applications of his work in the biopharmaceutical industry.
Career Highlights
Kalvin Yim works at Pharmathene, Inc., a company dedicated to developing the next generation of biopharmaceutical products. His innovative research has positioned him as a key player in the field, significantly advancing the understanding and application of BChE enzymes in medical treatments and therapies.
Collaborations
Throughout his career, Kalvin has collaborated with talented coworkers, including Steven Danso and Edward Hausknecht. These partnerships reflect a shared commitment to innovation and the pursuit of excellence in biopharmaceutical research.
Conclusion
Kalvin Yim's work exemplifies the importance of innovation in the biotechnology sector, particularly in the development of therapeutic enzymes. His contributions not only enhance scientific understanding but also provide valuable tools for future medical advancements.